Shares of Lonza Group AG (OTCMKTS:LZAGY – Get Rating) have been given an average rating of “Buy” by the eleven ratings firms that are covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, two have issued a hold rating and seven have given a buy rating to the company. The average 12 month price objective among brokers that have issued ratings on the stock in the last year is $842.50.
LZAGY has been the topic of a number of research analyst reports. Royal Bank of Canada raised Lonza Group from a “sector perform” rating to an “outperform” rating in a report on Friday. Morgan Stanley lowered their target price on shares of Lonza Group from CHF 800 to CHF 785 and set an “equal weight” rating on the stock in a report on Monday, April 4th. Zacks Investment Research cut shares of Lonza Group from a “hold” rating to a “sell” rating in a research note on Wednesday, March 30th. Finally, Stifel Nicolaus upgraded shares of Lonza Group from a “hold” rating to a “buy” rating in a research note on Thursday, February 10th.
Shares of LZAGY stock opened at $56.43 on Friday. The stock has a fifty day simple moving average of $64.73 and a two-hundred day simple moving average of $70.76. Lonza Group has a 52-week low of $51.78 and a 52-week high of $86.31.
Lonza Group Company Profile (Get Rating)
Lonza Group Ltd supplies products and services to the pharmaceutical, biotech, and nutrition markets in Switzerland and internationally. It operates through Biologics, Small Molecules, Cell and Gene, and Capsules and Health Ingredients divisions. The Biologics division engages in the contract development and manufacturing services for biopharmaceuticals.
- Get a free copy of the StockNews.com research report on Lonza Group (LZAGY)
- MarketBeat: Week in Review 5/16 – 5/20
- 3 Retailers That Defied First Quarter Headwinds
- Will John Deere’s Earnings Help to Calm the Markets?
- Rapid7: Could Be Profitable in FY 2022 Despite Bear Market
- Lowe’s Companies Has Not Bottomed
Receive News & Ratings for Lonza Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lonza Group and related companies with MarketBeat.com's FREE daily email newsletter.